ClinConnect ClinConnect Logo
Search / Trial NCT06862843

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

Launched by MEYER CHILDREN'S HOSPITAL IRCCS · Mar 3, 2025

Trial Information

Current as of November 10, 2025

Recruiting

Keywords

Jia Dietary Habits Cd Uc Ibd

ClinConnect Summary

This clinical trial is looking at how eating habits might affect families with members who have specific chronic health conditions, such as Juvenile Idiopathic Arthritis (JIA), Crohn’s Disease (CD), or Ulcerative Colitis (UC). The goal is to better understand how diet can impact these inflammatory diseases and explore new ways that dietary changes could help manage or even prevent these conditions. The study is part of a larger European research project focused on the connection between diet and health, particularly related to gut health.

To participate in this study, families need to have at least one child or adult who has JIA or inflammatory bowel disease (IBD), or they can be a healthy family without these conditions. The study is open to families with children ages 0-18, and both parents must be in good health. Participants will share information about their eating habits, and they can expect to help researchers learn more about how diet influences these chronic diseases. This is an important step toward discovering better dietary treatments for those affected by these conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • For families with at least one child/adult affected by IBD/JIA:
  • Father and mother with children aged between 0-18 years, in good health.
  • At least one adult or one child affected by IBD, or a child affected by JIA, regardless of ongoing therapy and without distinction of disease severity or activity.
  • For healthy families:
  • - Father and mother with children aged between 0-18 years, in good health and not affected by chronic inflammatory bowel diseases or chronic autoimmune inflammatory diseases in general.
  • Exclusion Criteria:
  • For subjects affected by IBD:
  • Monogenic disease
  • Children with an ileostomy or who have undergone a colectomy
  • For subjects affected by JIA:
  • - No exclusion criteria
  • For healthy subjects:
  • - Any chronic inflammatory bowel disease, autoimmune disease, or ongoing infectious diseases.

About Meyer Children's Hospital Irccs

Meyer Children's Hospital IRCCS is a leading pediatric research institution based in Italy, dedicated to advancing child healthcare through innovative clinical trials and research initiatives. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it combines clinical excellence with rigorous scientific inquiry, focusing on various pediatric conditions. The hospital collaborates with multidisciplinary teams to enhance treatment protocols, improve patient outcomes, and contribute to the global body of knowledge in pediatric medicine. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity and care.

Locations

Florence, Italy

Foggia, Italy

Palermo, Italy

Roma, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported